- Home
- BLCO vs SKT Comparison
BLCO vs SKT Comparison
Compare BLCO & SKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BLCO
- SKT
- Stock Information
- Founded
- BLCO 1853
- SKT 1981
- Country
- BLCO Canada
- SKT United States
- Employees
- BLCO N/A
- SKT N/A
- Industry
- BLCO Ophthalmic Goods
- SKT Real Estate Investment Trusts
- Sector
- BLCO Health Care
- SKT Real Estate
- Exchange
- BLCO Nasdaq
- SKT Nasdaq
- Market Cap
- BLCO 4.0B
- SKT 3.6B
- IPO Year
- BLCO 2022
- SKT 1993
- Fundamental
- Price
- BLCO $11.34
- SKT $30.02
- Analyst Decision
- BLCO Hold
- SKT Buy
- Analyst Count
- BLCO 12
- SKT 9
- Target Price
- BLCO $15.59
- SKT $36.00
- AVG Volume (30 Days)
- BLCO 1.1M
- SKT 1.2M
- Earning Date
- BLCO 04-30-2025
- SKT 04-30-2025
- Dividend Yield
- BLCO N/A
- SKT 3.89%
- EPS Growth
- BLCO N/A
- SKT N/A
- EPS
- BLCO N/A
- SKT 0.85
- Revenue
- BLCO $4,829,000,000.00
- SKT $549,227,000.00
- Revenue This Year
- BLCO $6.30
- SKT $0.30
- Revenue Next Year
- BLCO $5.56
- SKT $4.14
- P/E Ratio
- BLCO N/A
- SKT $35.46
- Revenue Growth
- BLCO 11.94
- SKT 12.63
- 52 Week Low
- BLCO $10.45
- SKT $25.94
- 52 Week High
- BLCO $21.69
- SKT $37.57
- Technical
- Relative Strength Index (RSI)
- BLCO 38.92
- SKT 40.74
- Support Level
- BLCO $10.83
- SKT $29.11
- Resistance Level
- BLCO $11.78
- SKT $30.19
- Average True Range (ATR)
- BLCO 0.57
- SKT 0.84
- MACD
- BLCO -0.03
- SKT -0.11
- Stochastic Oscillator
- BLCO 25.14
- SKT 22.97
About BLCO Bausch + Lomb Corporation
Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.
About SKT Tanger Inc.
Tanger Inc is an owners and operators of outlet and open-air centers in the United States and Canada. It is a fully-integrated, self-administered and self-managed REIT, which focuses on developing, acquiring, owning, operating and managing outlet and open-air shopping centers. Its consolidated portfolio consisted of 31 outlet centers and 2 open-air lifestyle centers, with a total gross leasable area of approximately 13.0 million square feet.